CATHETER RELATED BLOOD STREAM INFECTION MARKET ANALYSIS

Catheter Related Blood Stream Infection Market, by Drug Class (Non-antibiotic, Anti-infective, and Antimicrobial),By Pathogenesis (Contaminated Catheter Hub ,Contaminated Infusate ,Skin Insertion ,Hematogenous )By Source of Infection/Micro-organisms ( Staph. Aureus , P.aeruginsa ,CONS ,Aciento.Baumanii ,E.coli ,K. pnemoniae, Candida sp.) by Route of Administration (Oral and Intravenous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI4805
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Catheter Related Blood Stream Infection Market – Competitive landscape

Key players involved in the global catheter related blood stream infection include Citius Pharmaceuticals, CorMedix, Geistlich Pharma, TauroPharm GmbH, Fresenius Medical Care, AstraZeneca Pharma India Ltd., Glenmark Pharmaceuticals Ltd., Xellia Pharmaceuticals Ltd., and Pfizer.